MicroRNA expression profiling in tears and blood as predictive biomarkers for anti-VEGF treatment response in wet age-related macular degeneration
Tóm tắt
This study aimed to investigate the potential of microRNAs (miRNAs) in tears, blood, and aqueous humor as biomarkers for predicting treatment response in wet age-related macular degeneration (AMD) patients undergoing anti-vascular endothelial growth factor (anti-VEGF) therapy. In a single-center prospective cohort study, treatment-naïve wet AMD patients and age-matched controls were enrolled. Clinical data and miRNA levels (miR-199a-3p, miR-365-3p, miR-200b-3p, miR-195-5p, miR-335-5p, and miR-185-5p) in tears, blood, and aqueous humor were collected. Treatment response was categorized into responders and non-responders based on visual acuity and central subfield thickness. MiRNA levels were quantified using reverse-transcription PCR. Statistical analyses were performed, including ROC analysis, to evaluate predictive accuracy. Dysregulated miRNA profiles were observed in wet AMD tears and blood compared to controls. Specifically, miR-199a-3p, miR-195-5p, and miR-185-5p were upregulated, while miR-200b-3p was downregulated in tears. All six miRNAs were elevated in wet AMD blood samples. Notably, responders showed higher tear expression of miR-195-5p and miR-185-5p. Combining these miRNAs yielded the highest predictive power (AUC = 0.878, p = 0.006) for anti-VEGF responders. Dysregulated miRNA profiles in tears and blood suggest their potential as biomarkers for wet AMD. MiR-195-5p and miR-185-5p in tears demonstrate predictive value for anti-VEGF treatment responders. This study underscores the non-invasive prediction potential of miRNA tear analysis in wet AMD treatment responses.
Từ khóa
Tài liệu tham khảo
Li JQ, Welchowski T, Schmid M et al (2020) Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol 104(8):1077–1084. https://doi.org/10.1136/bjophthalmol-2019-314422
Colijn JM, Buitendijk GHS, Prokofyeva E et al (2017) Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology 124(12):1753–1763. https://doi.org/10.1016/j.ophtha.2017.05.035
Veritti D, Sarao V, Lanzetta P (2012) Neovascular age-related macular degeneration. Ophthalmologica 227(Suppl 1):11–20. https://doi.org/10.1159/000337154
Saxena N, George PP, Hoon HB et al (2016) The burden of wet age-related macular degeneration and its economic implications in singapore in the Year 2030. Ophthalmic Epidemiol 23(4):232–237. https://doi.org/10.1080/09286586.2016.1193617
Solomon SD, Lindsley K, Vedula SS et al (2014) Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 8(8):CD005139. https://doi.org/10.1002/14651858
CATT Research Group, Martin DF, Maguire MG, Ying GS et al (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 364(20):1897–908. https://doi.org/10.1056/NEJMoa1102673
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL et al (2012) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 119(7):1388–98. https://doi.org/10.1016/j.ophtha.2012.03.053
Mettu PS, Allingham MJ, Cousins SW (2021) Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res 82:100906. https://doi.org/10.1016/j.preteyeres.2020.100906
Amoaku WM, Chakravarthy U, Gale R et al (2015) Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond) 29(6):721–731. https://doi.org/10.1038/eye.2015.48
Barış ME, Menteş J, Afrashi F et al (2020) Subgroups and features of poor responders to anti-vascular endothelial growth factor treatment in eyes with neovascular age-related macular degeneration. Turk J Ophthalmol 50(5):275–282. https://doi.org/10.4274/tjo.galenos.2020.38488
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S et al (2019) An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol 234(5):5451–5465. https://doi.org/10.1002/jcp.27486
Hyttinen JMT, Blasiak J, Felszeghy S et al (2021) MicroRNAs in the regulation of autophagy and their possible use in age-related macular degeneration therapy. Ageing Res Rev 67:101260. https://doi.org/10.1016/j.arr.2021.101260
Romano GL, Platania CBM, Drago F et al (2017) Retinal and circulating miRNAs in age-related macular degeneration: An In vivo Animal and human study. Front Pharmacol 8:168. https://doi.org/10.3389/fphar.2017.00168
Chu-Tan JA, Rutar M, Saxena K et al (2018) MicroRNA-124 dysregulation is associated with retinal inflammation and photoreceptor death in the degenerating retina. Invest Ophthalmol Vis Sci 59(10):4094–4105. https://doi.org/10.1167/iovs.18-24623
Blasiak J, Watala C, Tuuminen R et al (2019) Expression of VEGFA-regulating miRNAs and mortality in wet AMD. J Cell Mol Med 23(12):8464–8471. https://doi.org/10.1111/jcmm.14731
Sun L, Liu X, Zuo Z (2021) Regulatory role of miRNA-23a in diabetic retinopathy. Exp Ther Med 22(6):1477. https://doi.org/10.3892/etm.2021.10912
Kim YJ, Yeon Y, Lee WJ et al (2019) Comparison of MicroRNA expression in tears of normal subjects and Sjögren syndrome patients. Invest Ophthalmol Vis Sci 60(14):4889–4895. https://doi.org/10.1167/iovs.19-27062
Raga-Cervera J, Bolarin JM, Millan JM et al (2021) miRNAs and Genes Involved in the Interplay between ocular hypertension and primary open-angle glaucoma oxidative stress, inflammation, and apoptosis networks. J Clin Med. 10(11):2227. https://doi.org/10.3390/jcm10112227
Wang Q, Xie X, Li H et al (2020) Discovery of microRNA expression profiles involved in regulating TGF-β2 expression in the tears of dry eye patients. Ann Clin Biochem 57(6):420–428. https://doi.org/10.1177/0004563220961746
Kim YJ, Yeon Y, Lee WJ et al (2022) Analysis of MicroRNA expression in tears of patients with herpes epithelial keratitis: a preliminary study. Invest Ophthalmol Vis Sci 63(4):21. https://doi.org/10.1167/iovs.63.4.21
Syed NH, Shahidan WNS, Shatriah I et al (2022) MicroRNA profiling of the tears of children with vernal keratoconjunctivitis. Front Genet 13:847168. https://doi.org/10.3389/fgene.2022.847168
Grieco GE, Sebastiani G, Eandi CM et al (2020) MicroRNA expression in the aqueous humor of patients with diabetic macular Edema. Int J Mol Sci 21(19):7328. https://doi.org/10.3390/ijms21197328
Zheng K, Wang N, Shen Y et al (2018) Pro-apoptotic effects of micro-ribonucleic acid-365 on retinal neurons by targeting insulin-like growth factor-1 in diabetic rats: An in vivo and in vitro study. J Diabetes Investig 9(5):1041–1051. https://doi.org/10.1111/jdi.12815
Wang J, Zhang J, Chen X et al (2018) miR-365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress. Exp Eye Res 168:89–99. https://doi.org/10.1016/j.exer.2017.11.006
Wang H, Wang Z, Tang Q (2018) Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus. Exp Ther Med 16(4):3639–3645. https://doi.org/10.3892/etm.2018.6655
Ren C, Liu Q, Wei Q et al (2017) Circulating miRNAs as potential biomarkers of age-related macular degeneration. Cell Physiol Biochem 41(4):1413–1423. https://doi.org/10.1159/000467941
Wu J, Chen J, Hu J et al (2023) CircRNA Uxs1/miR-335-5p/PGF axis regulates choroidal neovascularization via the mTOR/p70 S6k pathway. Transl Res 256:41–55. https://doi.org/10.1016/j.trsl.2023.01.003
Friedrich J, Steel DHW, Schlingemann RO et al (2023) microRNA expression profile in the vitreous of proliferative diabetic retinopathy patients and differences from patients treated with Anti-VEGF therapy. Transl Vis Sci Technol 9(6):16. https://doi.org/10.1167/tvst.9.6.16
Cho H, Hwang M, Hong EH et al (2020) Micro-RNAs in the aqueous humour of patients with diabetic macular oedema. Clin Exp Ophthalmol 48(5):624–635. https://doi.org/10.1111/ceo.13750
Natoli R, Fernando N (2018) MicroRNA as therapeutics for age-related macular degeneration. Adv Exp Med Biol 1074:37–43. https://doi.org/10.1007/978-3-319-75402-4_5
Urbańska K, Stępień PW, Nowakowska KN et al (2022) The role of dysregulated miRNAs in the pathogenesis, diagnosis and treatment of age-related macular degeneration. Int J Mol Sci 23(14):7761. https://doi.org/10.3390/ijms23147761
Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733–1741. https://doi.org/10.1373/clinchem.2010.147405
Hindle AG, Thoonen R, Jasien JV et al (2019) Identification of candidate miRNA biomarkers for glaucoma. Invest Ophthalmol Vis Sci 60(1):134–146. https://doi.org/10.1167/iovs.18-24878
Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87(2):262–271. https://doi.org/10.1093/cvr/cvq105
Ishikawa K, Kannan R, Hinton DR (2016) Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res 142:19–25. https://doi.org/10.1016/j.exer.2015.03.009
Sato T, Takeuchi M, Karasawa Y et al (2018) Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor. Sci Rep 8(1):1098. https://doi.org/10.1038/s41598-018-19594-6
Damico FM, Gasparin F, Scolari MR et al (2012) New approaches and potential treatments for dry age-related macular degeneration. Arq Bras Oftalmol 75(1):71–76. https://doi.org/10.1590/s0004-27492012000100016
Armstrong DA, Green BB, Seigne JD et al (2015) MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol Cancer 14:194. https://doi.org/10.1186/s12943-015-0466-2
Zhang Y, Zhang D, Wang F et al (2015) Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep 5:17942. https://doi.org/10.1038/srep17942
Jin Y, Wang M, Hu H et al (2018) Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling. Int J Biol Macromol 117:445–453
Wu J, Ji A, Wang X et al (2015) MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells. J Transl Med 13:289
Dai J, Wei R, Zhang P (2022) Retraction Note: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway. J Transl Med 20(1):351. https://doi.org/10.1186/s12967-022-03560-y
Wang R, Zhao N, Li S et al (2013) MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 58:642–653
Ma X, Liu H, Zhu J et al (2022) miR-185-5p regulates inflammation and phagocytosis through CDC42/JNK pathway in macrophages. Genes (Basel) 13(3):468. https://doi.org/10.3390/genes13030468
Tian J, Cheng L, Kong E et al (2022) linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer. Reprod Biol Endocrinol 20(1):132. https://doi.org/10.1186/s12958-022-00995-2